This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Zaman F, Fadeel B, Savendahl L . Proteasome inhibition therapies in childhood cancer. Leukemia 2008; 22: 883–884.
Terpos E, Dimopoulos MA, Sezer O . The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma. Leukemia 2007; 21: 1875–1884.
Zaman F, Menendez-Benito V, Eriksson E, Chagin AS, Takigawa M, Fadeel B et al. Proteasome inhibition up-regulates p53 and apoptosis-inducing factor in chondrocytes causing severe growth retardation in mice. Cancer Res 2007; 67: 10078–10086.
Terpos E, Sezer O, Croucher PI, Dimopoulos MA . Myeloma bone disease and proteasome inhibition therapies. Blood 2007; 110: 1098–1104.
von Metzler I, Krebbel H, Hecht M, Manz RA, Fleissner C, Mieth M et al. Bortezomib inhibits human osteoclastogenesis. Leukemia 2007; 21: 2025–2034.
Terpos E, Heath DJ, Rahemtulla A, Zervas K, Chantry A, Anagnostopoulos A et al. Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappa B ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma. Br J Haematol 2006; 135: 688–692.
Palombella VJ, Rando OJ, Goldberg AL, Maniatis T . The ubiquitin–proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 1994; 78: 773–785.
Giuliani N, Morandi F, Tagliaferri S, Lazzaretti M, Bonomini S, Crugnola M et al. The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients. Blood 2007; 110: 334–338 .
Wu S, De Luca F . Inhibition of the proteasomal function in chondrocytes down-regulates growth plate chondrogenesis and longitudinal bone growth. Endocrinology 2006; 147: 3761–3768.
Alexander DD, Mink PJ, Adami HO, Cole P, Man del JS, Oken MM et al. Multiple myeloma: a review of the epidemiologic literature. Int J Cancer 2007; 120 (Suppl 12): 40–61.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Terpos, E., Sezer, O. Reply to ‘Proteasome inhibition therapies in childhood cancer’ by Zaman et al.. Leukemia 22, 884–885 (2008). https://doi.org/10.1038/sj.leu.2404998
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404998